Buscar
Mostrando ítems 1-2 de 2
Less hepatic decompensation events but rising liver cancer in hepatitis B patients on long-term nucleos(t)ide therapy
(AIDS Reviews, 2022)
[Abstract not available]
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
(Elsevier B.V., 2022)
Viral hepatitis is among the top four causes of mortality globally, causing 1.4 million deaths each year, exceeding tuberculosis, malaria and human immunodeficiency virus. Hepatitis B and C are responsible for 90% of ...